PharmaTimes: News RSS

Symkevi/Kalydeco cleared for use in young CF patients

Fri, 27 Nov 2020 09:47:41 GMT

The combination is the first available to treat the underlying cause of CF in this patient group.

EU to review Merck's targeted lung cancer drug

Fri, 27 Nov 2020 09:27:13 GMT

Tepotinib could be the first treatment on the market for NSCLC in adults harbouring METex14 skipping alterations

NICE turns down Novartis' Adakveo

Fri, 27 Nov 2020 09:24:20 GMT

Trial results and cost-effectiveness are too uncertain for NHS use, the Institute said

NHS to trial innovative cancer blood test

Fri, 27 Nov 2020 09:20:15 GMT

It is hoped that the test will help detect cancer at a much earlier stage

NICE backs use of new treatment for multiple myeloma

Thu, 26 Nov 2020 10:36:07 GMT

Sanofi's Sarclisa gets the final green light for use by the NHS with funding from the CDF

Moderna signs deal with EU for 160 million COVID-19 vaccine doses

Thu, 26 Nov 2020 10:35:25 GMT

Delivery of vaccine doses to EU could begin by early 2021

Janssen's Tremfya approved for active psoriatic arthritis

Thu, 26 Nov 2020 10:34:59 GMT

Tremfya is a first-in-class treatment for the disease, shown to improve disease measures and quality of life

Mixed reaction to chancellor's spending review

Thu, 26 Nov 2020 09:12:19 GMT

Chancellor Rishi Sunak hands out extra £3 billion to NHS and £14.6 billion in funding for R&D

COVID-19 pandemic has emphasised existing health inequalities, research finds

Wed, 25 Nov 2020 09:19:23 GMT

New report conducted by Imperial College London researchers and Philips UK highlights issues within the NHS

BMS inks drug discovery deal with Schrödinger

Wed, 25 Nov 2020 09:19:07 GMT

Deal will focus on developing small molecules against a number of diseases

Over half of pharmacists report that COVID-19 has impacted their mental health

Wed, 25 Nov 2020 09:18:36 GMT

Survey from The Royal Pharmacy Society shows impact of pandemic on pharmacists’ mental health

GSK launches late-stage study of RSV vaccine in pregnant mothers

Wed, 25 Nov 2020 09:17:40 GMT

Shot will be evaluated in pregnant mothers and their newborn infants

Amgen hands back heart failure programme rights to Cytokinetics

Tue, 24 Nov 2020 09:30:52 GMT

Omecamtiv mecarbil and AMG 594 rights transitioned back to biotech

NICE backs Braftovi for BRAF-positive colorectal cancer

Tue, 24 Nov 2020 09:29:41 GMT

Positive recommendation follows initial rejection in September

FDA approves new dosing option for AZ’s Imfinzi

Tue, 24 Nov 2020 09:28:30 GMT

Less-frequent, fixed-dose use approved for two cancer indications

Sanofi’s meningococcal vaccine wins EU approval

Tue, 24 Nov 2020 09:27:37 GMT

MenQuadfi approved for vaccination in individuals 12 months of age or older

Annual pharma R&D spending in UK climbed 6.9% in 2019

Mon, 23 Nov 2020 09:25:35 GMT

R&D spending in the sector last year represents an eight-year high

Lilly to collaborate with Precision BioSciences on genome editing research

Mon, 23 Nov 2020 09:23:14 GMT

Lead programme will focus on developing therapies for Duchenne muscular dystrophy

Spending boost ‘welcome’ but more funding needed, says NHS Confed chief exec

Mon, 23 Nov 2020 09:21:41 GMT

Health leaders respond to reported £3bn funding boost

AZ/Oxford University’s COVID-19 vaccine shows average efficacy of 70%

Mon, 23 Nov 2020 09:19:59 GMT

Effectiveness ranges from 62% to 90% depending on dosing regimen